Correlation between the expression of cancer stem cell marker BMI1 and glioma prognosis
- 1 April 2021
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 550, 113-119
Abstract
No abstract availableKeywords
Funding Information
- Taipei Medical University Hospital
- Republic of China Ministry of Science and Technology
This publication has 28 references indexed in Scilit:
- Increased activation of HDAC1/2/6 and Sp1 underlies therapeutic resistance and tumor growth in glioblastomaNeuro-Oncology, 2020
- BMI1 Inhibition Eliminates Residual Cancer Stem Cells after PD1 Blockade and Activates Antitumor Immunity to Prevent Metastasis and RelapseCell Stem Cell, 2020
- Understanding Glioblastoma Biomarkers: Knocking a Mountain with a HammerCells, 2020
- BMI1 regulates androgen receptor in prostate cancer independently of the polycomb repressive complex 1Nature Communications, 2018
- Stress stimuli induce cancer-stemness gene expression via Sp1 activation leading to therapeutic resistance in glioblastomaBiochemical and Biophysical Research Communications, 2017
- Specificity protein 1-modulated superoxide dismutase 2 enhances temozolomide resistance in glioblastoma, which is independent of O6-methylguanine-DNA methyltransferaseRedox Biology, 2017
- Regulation of gene transcription by Polycomb proteinsScience Advances, 2015
- Role of BMI1, a Stem Cell Factor, in Cancer Recurrence and Chemoresistance: Preclinical and Clinical EvidencesStem Cells, 2012
- Identification of human brain tumour initiating cellsNature, 2004
- Bmi1, stem cells, and senescence regulationJournal of Clinical Investigation, 2004